Tokyo, Japan

Hisako Ohgawara

This inventor holds 1 USPTO granted patent. Top assignee: Keio University. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hisako Ohgawara. Retrieved from https://idiyas.com/inventor/hisako-ohgawara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hisako Ohgawara: Innovator in Insulin Production

Introduction

Hisako Ohgawara is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmacology, particularly in the area of insulin production. Her innovative work has the potential to impact diabetes treatment and management.

Latest Patents

Hisako Ohgawara holds a patent for the "Use of vinca alkaloids and salts thereof." This patent describes an agent containing a vinca alkaloid or its pharmacologically acceptable salt as an active ingredient that can induce insulin production and/or secretion of non-neoplastic cells derived from the pancreas. This groundbreaking discovery opens new avenues for diabetes therapies.

Career Highlights

Ohgawara is affiliated with Keio University, where she conducts her research and development. Her work at this prestigious institution has allowed her to explore innovative solutions in the medical field. She has been recognized for her contributions to pharmacology and continues to advance her research.

Collaborations

Throughout her career, Hisako Ohgawara has collaborated with notable colleagues, including Kazuo Umezawa and Itaru Kojima. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.

Conclusion

Hisako Ohgawara is a trailblazer in the field of pharmacology, with her patent on vinca alkaloids showcasing her innovative spirit. Her work at Keio University and collaborations with esteemed colleagues further highlight her commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…